1,1′-Binaphthylazepine-based ligands for asymmetric catalysis. Part 1: Preparation and characterization of some new aminoalcohols and diamines

Starting from (S)-1,1′-binaphthol, a series of ten novel enantiopure 1,1′-binaphthylazepine-based aminoalcohols and diamines 1a–1j were efficiently prepared and fully characterized. These derivatives, having either only an atropisomeric bridged-binaphthyl backbone or an additional stereogenic carbon center, can be interesting ligands for asymmetric catalysis.     

A new practical synthesis of silyl enol ethers : II. From α,β-unsaturated aldehydes and ketones

In acetonitrile as the solvent and in the presence of a tertiary amine the trimethylchlorosilane/sodium iodide (trimethyliodosilane “in situ”) reagent provides the corresponding siloxy dienes when reacted with α,β-unsaturated series. These reactions occurs via the formation of 1,2 or -1,4 onium salt intermediates.     

1,1′-Binaphthylazepine-based ligands for asymmetric catalysis. Part 2: New aminoalcohols as chiral ligands in the enantioselective addition of ZnEt2 to aromatic aldehydes

The new enantiopure 1,2-aminoalcohols 1b–1h having 1,1′-binaphthylazepine skeleton have been tested as catalytic precursors in the enantioselective addition of ZnEt₂ to benzaldehyde. The best results were seen with ligand 1d, which owes its chirality only to the atropisomerism of the binaphthyl nucleus and does not have any stereogenic carbon atom. In the presence of 1d benzaldehyde was quickly and cleanly transformed to (S)-1-phenylpropanol in 99% yield and 87% e.e. The same ligand was also used in the asymmetric ZnEt₂ addition to other aryl aldehydes giving rise to (S)-1-arylpropanols in almost quantitative yields and e.e.s up to 90%.     

Enantiomerically pure pyridine and 2,2′-bipyridine thioethers: new N–S chiral ligands for asymmetric catalysis. Palladium-catalyzed allylic alkylation

Diastereomeric pure pyridine and 2,2′-bipyridine thioethers, derived from (+)-camphor, were prepared and assessed in the enantioselective palladium-catalyzed allylic substitution of 1,3-diphenylprop-2-enyl acetate with dimethyl malonate. Enantioselectivities of up to 76% were obtained.     

Chiral ligands derived from abrine. Part 7: Effect of O,S, N in aromatic ring substituents at C-1 on enantioselectivity induced by tetrahydro-β-carboline ligands in diethylzinc addition to aldehydes

The effect of O, S and N atoms in aromatic ring substituents at C-1 position of tetrahydro-β-carboline ligands on the enantioselectivity of diethylzinc additions to benzaldehyde was studied when esters or tertiary alcohol functions were present at C-3. A mechanism is proposed to explain why the ester ligands 2c and 2d, in which the pyridyl N atom is at C′-2 in 2c and at C′-3 in 2d, catalyzed the addition of diethylzinc to benzaldehyde to form the (R)- and (S)-enantiomers of 1-phenyl-1-propanol, respectively. An explanation was also proposed for the moderate enantioselectivity induced by tert-alcohol 3c versus the very small enantioselectivity induced by 3d, containing a 3-pyridyl function at C-1, during diethylzinc additions. A -CH₂-t-Bu substituent at C-1 leads to very high enantioselectivities.     

Chiral 2-(2-phenylthiophenyl)-5,6,7,8-tetrahydroquinolines: new N–S ligands for asymmetric catalysis: Palladium-catalyzed allylic alkylation and copper-catalyzed cyclopropanation reactions

Diastereomeric pure 2-(2-phenylthiophenyl)-5,6,7,8-tetrahydroquinolines were prepared and assessed in the enantioselective palladium-catalyzed allylic substitution of 1,3-diphenylprop-2-enyl acetate with dimethyl malonate and in the copper-catalyzed cyclopropanation of styrene with ethyldiazoacetate. Enantioselectivity up to 63% was obtained.     

Enantioselective synthesis of β-amino acids. Part 10: Preparation of novel α,α- and β,β-disubstituted β-amino acids from (S)-asparagine

Perhydropyrimidinone (S)-1 is alkylated with very high diastereoselectivity to give trans products (2S,5R)-3, (2S,5R)–4 and (2S,5R)-5. Dialkylation of (S)-1 also proceeds with complete stereoselectivity to afford adducts (2S,5R)-6, (2S,5S)-6, (2S,5R)-7 and (2S,5S)-7. Hydrolysis (6N HCl, 100°C) of monoalkylated derivative (2S,5R)-3 gives enantiopure α-substituted β-amino acid (R)-8. Hydrolysis of dialkylated adducts 6 and 7 affords enantiopure α,α-disubstituted β-amino acids (R)- or (S)-9 and (R)- or (S)-10. Related iminoester (2S,6S)-2 is alkylated with complete diastereoselectivity to give products (2S,6S)-11–13 whose hydrolysis under relatively mild conditions (2N CF₃CO₂H, CH₃OH, 100°C) affords enantiopure N-benzoylated β,β-disubstituted β-amino acid esters (S)-14–16, with intact double bonds in the olefinic substituents.     

Optically active transition metal complexes. Part 117:Synthesis,crystal structure and properties of chiral (η6-arene)ruthenium complexes with N,O- and N,N-ligands

The complexes [(η⁶-p-ⁱPrC₆H₄Me)Ru(NO₂pesa)Cl] 2, [(η⁶-p-ⁱPrC₆H₄Me)Ru(oxazsa)Cl] 3 and [(η⁶-p-ⁱPrC₆H₄Me)Ru(pepy)Cl] 4, chiral in the chelate ligand and chiral at the ruthenium atom, have been prepared by reaction of [(η⁶-p-ⁱPrC₆H₄Me)RuCl₂]₂ with the anions of the (S)-configured bidentate N,O- and N,N-ligands. [(η⁶-p-ⁱPrC₆H₄Me)Ru(pesa)I] 5 was synthesized by halide exchange. The diastereomer ratios of compounds 2–4 with respect to the stereogenic ruthenium atom are in CDCl₃ 2a:2b=81:19, 3a:3b=77:23 and 4a:4b=61:39. Compound 5 is obtained diastereomerically pure. An X-ray structure analysis of 3 shows (R_Ru,S_C)-configuration     

Rifamycin antibiotics—new compounds and synthetic methods. Part 3: Study of the reaction of 3-formylrifamycin SV with primary amines and ketones

In the third stage of our study concerning the search for new antibacterial rifamycin antibiotics, the reactions of 3-formylrifamycin SV (1) with a range of primary alkylamines and ketones of general structure R₁–CH₂–CO–R₂ (R₁H or alkyl and R₂alkyl or aryl) has been investigated. A new synthetic method for the preparation of a new group of rifamycin derivatives with an α,β-unsaturated imine substituent at C-3 has been developed.These compounds showed a tendency to reversibly isomerise in organic solvents and, in the presence of water, to rapidly hydrolyse. The structures of four isolated microcrystalline compounds 2, 3, 4, 5 and a reaction's mechanism have been proposed on the basis of mass spectrometry results as well as (1D) and (2D) ¹H and ¹³C NMR analysis. The new synthetic route reported herein is a promising pathway to new reactive rifamycins displaying broader capabilities than the plain 3-formylrifamycin SV.     

Enantioselective hydrogenation of (Z)- and (E)-β-arylenamides catalyzed by rhodium complexes of monodentate chiral spiro phosphorous ligands: a new access to chiral β-arylisopropylamines

A highly enantioselective rhodium-catalyzed hydrogenation of both (Z)- and (E)-β-arylenamides was developed by using monodentate chiral spiro phosphite and phosphine ligands, respectively. The hydrogenation reaction provides an efficient access to optically active β-arylisopropylamines, important building blocks for the synthesis of biologically active compounds.     

Functionalized cyclopalladated compounds with bidentate Group 15 donor atom ligands: the crystal and molecular structures of [{Pd[5-(COH)C6H3C(H)NCy-C2,N](Cl)}2(μ-Ph2PRPPh2)] (R=CH2CH2, Fe(C5H4)2], [Pd{5-(COH)C6H3C(H)NCy-C2,N}(Ph2PCH2PPh2-P,P)][PF6] and [Pd{5-(COH)C6H3C(H)N(Cy)-C2,N}(Ph2PCH2CH2AsPh2-P,As)][PF6]

The chloro-bridged dinuclear compound [{Pd[5-(COH)C₆H₃C(H)N(Cy)-C2,N]}(μ-Cl)]₂ (1), reacts with tertiary diphosphines in 1:1 molar ratio to give [{Pd[5-(COH)C₆H₃C(H)NCy-C2,N](Cl)}₂(μ-Ph₂PRPPh₂)] (R: CH₂, 2; CH₂CH₂, 3; (CH₂)₄, 4; (CH₂)₆, 5; Fe(C₅H₄)₂, 6; trans-CHCH, 7; C≡C, 8). Treatment of 1 with Ph₂PCH₂CH₂AsPh₂ (arphos) gives the dinuclear complex [{Pd[5-(COH)C₆H₃C(H)N(Cy)-C2,N](Cl)}₂(μ-Ph₂PCH₂CH₂AsPh₂)] (9). The reaction of 1 with tertiary diphosphines or arphos in 1:2 molar ratio in the presence of NH₄PF₆ yields the mononuclear compounds [Pd{5-(COH)C₆H₃C(H)NCy-C2,N}(Ph₂PRPPh₂-P,P)][PF₆] (R: (CH₂)₄, 10; (CH₂)₆, 11; Fe(C₅H₄)₂, 12; 1,2-C₆H₄, 13; cis-CHCH, 14; NH, 15) and [Pd{5-(COH)C₆H₃C(H)N(Cy)-C2,N}(Ph₂PCH₂CH₂AsPh₂-P,As)][PF₆] (16). ¹H-, ³¹P-{¹H}- and ¹³C-{¹H}-NMR, IR and mass spectroscopic data are given. The crystal structures of compounds 3, 6, 9 and 16 have been determined by X-ray crystallography.     

Allyl complexes of molybdenum with Schiff base ligands. The crystal structures of [MoCl(CO)2{N(C6H4-2-OMe)C(Me)C5H4N}(η-C3H5)] and [MoCl(CO)2{N(Me)C(Ph)C5H4N}(η-C3H5)] are described

Treatment of the molybdenum tetracarbonyl complexes of [Mo(CO)₄L₂] (L₂=pyridyl amine Schiff base ligands) with allyl chloride in refluxing THF afforded η³-allyl complexes [MoCl(CO)₂L₂(η³-allyl)] (1-9). These complexes have been characterised by various techniques including ¹H-NMR, IR and FABMS spectroscopies and the single crystal X-ray structure determinations of the complexes [MoCl(CO)₂{N(C₆H₄-2-OMe)C(Me)C₅H₄N}(η³-C₃H₅)] (3) and [MoCl(CO)₂{N(Me)C(Ph)C₅H₄N}(η³-C₃H₅)] (4).